# Mobilization of Endothelial Progenitor Cells Induced by Atorvastatin in Patients With Stable Coronary Artery Disease Treated With Anti-CD 34 Antibodies Coated Stents

> **NCT00911339** · PHASE3 · TERMINATED · sponsor: **Fondazione IRCCS Policlinico San Matteo di Pavia** · enrollment: 13 (actual)

## Conditions studied

- Stable Coronary Artery Disease

## Interventions

- **DRUG:** Atorvastatin
- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT00911339
- **Lead sponsor:** Fondazione IRCCS Policlinico San Matteo di Pavia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-01
- **Primary completion:** 2021-05-13
- **Final completion:** 2021-05-13
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** prematurely interrupted because of difficulty in enrolment of patients.
- **Last updated:** 2021-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00911339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00911339, "Mobilization of Endothelial Progenitor Cells Induced by Atorvastatin in Patients With Stable Coronary Artery Disease Treated With Anti-CD 34 Antibodies Coated Stents". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00911339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*